Meridian Bioscience Inc. (VIVO) financial statements (2021 and earlier)

Company profile

Business Address 3471 RIVER HILLS DR
CINCINNATI, OH 45244
State of Incorp. OH
Fiscal Year End September 30
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments63546260574750
Cash and cash equivalents63546260574750
Receivables41393632292726
Inventory, net of allowances, customer advances and progress billings67614042414536
Inventory67614042414536
Other undisclosed current assets69756711
Total current assets:178162145139134127123
Noncurrent Assets
Property, plant and equipment36313130313027
Intangible assets, net (including goodwill)    829228
Goodwill    556222
Intangible assets, net (excluding goodwill)    27306
Derivative instruments and hedges    1  
Restricted cash and investments    111
Other noncurrent assets21021215082000
Other undisclosed noncurrent assets    213
Total noncurrent assets:24624318111211612560
TOTAL ASSETS:424405325251250252183
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities40382119161915
Accounts payable151276887
Accrued liabilities6545333
Employee-related liabilities111787575
Taxes payable8420111
Debt   554 
Business combination, contingent consideration, liability1113  2  
Other undisclosed current liabilities32     
Total current liabilities:54532124232315
Noncurrent Liabilities
Long-term debt and lease obligation637476455055 
Long-term debt, excluding current maturities596976455055 
Operating lease, liability55 
Liabilities, other than long-term debt152037667 
Accounts payable and accrued liabilities0110   
Deferred tax liabilities, net443 
Deferred income tax liabilities342
Liability, pension and other postretirement and postemployment benefits 22222 
Other liabilities00     
Business combination, contingent consideration, liability111332 02 
Derivative instruments and hedges, liabilities11   1 
Other undisclosed noncurrent liabilities131111112
Total noncurrent liabilities:911051145257632
Total liabilities:14515813576808517
Stockholders' equity
Stockholders' equity attributable to parent279248191175170166166
Additional paid in capital141140133129126122117
Accumulated other comprehensive income (loss)1(2)(5)(3)(3)(6)(2)
Retained earnings1361096350475051
Total stockholders' equity:279248191175170166166
TOTAL LIABILITIES AND EQUITY:424405325251250252183

Income statement (P&L) ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
Revenues299254201214201196195
Revenue, net201196195
Cost of revenue
(Cost of Goods and Services Sold)
(109)(97)(83)(83)(76)(68)(73)
Gross profit:190156118130125128122
Operating expenses(100)(95)(86)(99)(87)(76)(66)
Operating income:91613332375156
Nonoperating expense(1)(2)(1)(1)(1)(1)(1)
Investment income, nonoperating0010000
Foreign currency transaction loss, before tax      (1)
Other nonoperating income (expense)000(0)10(1)
Interest and debt expense(2)(3)(2)(2)(2)(1) 
Income from continuing operations before equity method investments, income taxes:87573029355055
Other undisclosed income from continuing operations before income taxes232221 
Income from continuing operations before income taxes:90593230365155
Income tax expense(19)(13)(7)(7)(15)(18)(20)
Net income available to common stockholders, diluted:70462424223236

Comprehensive Income ($ in millions)

12/31/2020
TTM
9/30/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
Net income:70462424223236
Comprehensive income:70462424223236
Other undisclosed comprehensive income (loss), net of tax, attributable to parent43(2)(0)3(3)(3)
Comprehensive income, net of tax, attributable to parent:74492323242933

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: